Procept (PRCT): 50% rise on high volume. Why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?

PRCT 31.91

+1.9%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gerald Thomas who wrote (231)	8/13/1997 11:26:00 AM
From: Trumptown	of 455

Any ideas on what this is all about? Procept Initiates Drug Discovery Agreement CAMBRIDGE, Mass.--(BW HealthWire)--Aug. 13, 1997--Procept, Inc. (NASDAQ:PRCT) today announced a drug screening arrangement with Abbott Laboratories to identify potential drug candidates by applying Abbott's SAR by NMR technology to an undisclosed target from Procept. No additional terms of the agreement were disclosed. Procept, Inc. is engaged in the research and development of small molecule therapeutics for the prevention and treatment of chronic and life-threatening immune system disorders. Procept is developing therapeutics for the treatment of autoimmune disease, organ transplant rejection and infectious diseases, such as AIDS and tuberculosis. Founded in 1985 and traded on the Nasdaq National Market System under the symbol PRCT, Procept is located in Cambridge, Massachusetts.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next